1832 Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
BCM
1832 Asset Management's ABMD Position: Q4 2019 in Review
1832 Asset Management sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 28,000 shares — an estimated $4.92M sold.
1832 Asset Management first reported a position in ABMD in Q1 2015 and held it in 16 quarters. The position peaked at $194M in Q4 2016. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.
- 1832 Asset Management reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
- 1832 Asset Management sold 28,000 Abiomed Inc shares in Q4 2019, an estimated $4.92M.
- 1832 Asset Management first reported a position in Abiomed Inc in Q1 2015 and held it in 16 quarters.
- 1832 Asset Management's Abiomed Inc position peaked at $194M in Q4 2016.
- 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.
Based on 1832 Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.